{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Introduction to GLP-1 Medications",
      "startTime": 37.19,
      "endTime": 100.02
    },
    {
      "title": "Meet Dr. Arne Astrup",
      "startTime": 100.02,
      "endTime": 251.73
    },
    {
      "title": "The 1990s Obesity Landscape",
      "startTime": 251.73,
      "endTime": 365.6
    },
    {
      "title": "Collaboration and Discovering GLP-1",
      "startTime": 365.6,
      "endTime": 658.87
    },
    {
      "title": "GLP-1's Journey to Medication",
      "startTime": 658.87,
      "endTime": 811.17
    },
    {
      "title": "Why GLP-1s Are More Effective",
      "startTime": 811.17,
      "endTime": 1030.05
    },
    {
      "title": "Understanding GLP-1 Receptors",
      "startTime": 1030.05,
      "endTime": 1207.75
    },
    {
      "title": "Muscle Mass Concerns",
      "startTime": 1207.75,
      "endTime": 1651.08
    },
    {
      "title": "The Role of Lifestyle",
      "startTime": 1651.08,
      "endTime": 1865.67
    },
    {
      "title": "Debunking the Easy Way Out Myth",
      "startTime": 1865.67,
      "endTime": 2016.35
    },
    {
      "title": "The Food Environment Challenge",
      "startTime": 2016.35,
      "endTime": 2281.96
    },
    {
      "title": "Rapid Fire Questions",
      "startTime": 2281.96,
      "endTime": 2417.7
    },
    {
      "title": "Future Aspirations in Obesity Research",
      "startTime": 2417.7,
      "endTime": 2623.36
    },
    {
      "title": "Conclusion and Reflections",
      "startTime": 2623.36,
      "endTime": 2678.13
    }
  ]
}